您的位置: 首页 > 农业专利 > 详情页

TARGETS FOR SIGNALS OF GROWTH FACTOR AND METHODS OF TREATMENT
专利权人:
КВИНСЛЕНД ЮНИВЕРСИТИ ОФ ТЕКНОЛОДЖИ (AU)
发明人:
КРОЛЛ Тристан (AU),ПИТ Джесс (AU),РИЦЦИ Симоне (CH),ШУТЕР Гари Кейт (AU),АПТОН Зи (AU),ВАН ЛОНКХЕЙЗЕН Дерек (AU)
申请号:
RU2011142172/15
公开号:
RU2011142172A
申请日:
2010.03.19
申请国别(地区):
RU
年份:
2013
代理人:
摘要:
1. A method for screening, constructing, developing or otherwise producing a therapeutic agent effective for treating a transglutaminase-associated disorder, disease and / or condition, wherein said method comprises the step of determining whether the candidate agent is capable of modulating the interaction between (i) TG and IGF; and / or (ii) TG and a member of the IGF.2 receptor family. The method of claim 1, wherein the IGF is selected from IGF-I and IGF-II. The method of claim 2, wherein the IGF is IGF-I.4. The method of claim 1, wherein the member of the IGF receptor family is selected from the group consisting of IGF-1R, an insulin receptor, an insulin receptor-related receptor, and a hybrid IGF insulin receptor. The method of claim 4, wherein the member of the IGF receptor family is selected from the group consisting of IGF-1R, an insulin receptor, and a hybrid IGF insulin receptor. The method of claim 5, wherein the member of the IGF receptor family is selected from IGF-1R and a hybrid IGF-insulin receptor. The method of claim 6, wherein the member of the IGF receptor family is IGF-1R.8. The method of claim 1, wherein the TG is selected from the group consisting of FXIII, TG1, TG2, TG3, TG4, TG5, TG6, and TG7.9. The method of claim 1, wherein the TG is selected from FXIII and TG2.10. The method of claim 9, wherein the TG is TG2.11. The method of claim 1, wherein said candidate agent is a modulator selected from the group consisting of an isolated peptide, an isolated polypeptide, an antibody, an isolated nucleic acid, and a small organic molecule. The method of claim 11, wherein said antibody is a monoclonal antibody. The method according to claim 11, according to1. Способ скрининга, конструирования, разработки или иного пути продуцирования терапевтического средства, эффективного для лечения ассоциированного с трансглутаминазой расстройства, заболевания и/или состояния, где указанный способ включает стадию определения того, способно ли средство-кандидат мод
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充